CoChat

Aging Biology and Novel Targets for Drug Discovery

Open access
Le Couteur, D. G., McLachlan, A. J., Quinn, R. J., Simpson, S. J., de Cabo, R. · 2012 · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences
Cited by 60

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

Despite remarkable technological advances in genetics and drug screening, the discovery of new pharmacotherapies has slowed and new approaches to drug development are needed. Research into the biology of aging is generating many novel targets for drug development that may delay all age-related diseases and be used long term by the entire population. Drugs that successfully delay the aging process will clearly become "blockbusters." To date, the most promising leads have come from studies of the cellular pathways mediating the longevity effects of caloric restriction (CR), particularly target of rapamycin and the sirtuins. Similar research into pathways governing other hormetic responses that influence aging is likely to yield even more targets. As aging becomes a more attractive target for drug development, there will be increasing demand to develop biomarkers of aging as surrogate outcomes for the testing of the effects of new agents on the aging process.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/gerona/glr095

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 20 references

Cited by

See all 60

Metadata

Authors
Le Couteur, D. G., McLachlan, A. J., Quinn, R. J., Simpson, S. J., & de Cabo, R.
Venue
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences
Published
2011-06-21
Volume
67A
Issue
2
Pages
168-174
ISSN
  • 1079-5006 (ISSN-L)
  • 1758-535X
OpenAlex
W2136700311
Cited by
60
References
20
FWCI
2.34
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Aging Biology and Novel Targets for Drug Discovery. https://app.cochat.ai/papers/10.1093/gerona/glr095
The paper
Le Couteur, D. G., McLachlan, A. J., Quinn, R. J., Simpson, S. J., & de Cabo, R. (2012). Aging Biology and Novel Targets for Drug Discovery. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. https://doi.org/10.1093/gerona/glr095

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.